Navigation Links
Chemotherapy After Breast Cancer Surgery Effective for Older Women, Too
Date:2/17/2008

But many patients aren't getting the lifesaving treatment, research reveals,,,,

SUNDAY, Feb. 17 (HealthDay News) -- It's clear that chemotherapy after breast cancer surgery increases survival rates. But many older women aren't being offered this potentially lifesaving treatment.

But, age shouldn't be a deciding factor -- an older woman's general health appears to be a better predictor of positive results after chemotherapy, according to a study published recently in the Journal of the American Medical Association.

"Age alone should not be a contraindication to the use of optimal chemotherapy regimens in older women who are in good general health," the study authors said.

About half of all breast cancers in the United States occur in women older than 65. Past studies have shown that chemotherapy after breast cancer surgery increases the odds of disease-free survival in women between the ages of 50 and 69. But little information has been available for treating women over 70, the study authors said.

One important concern is that older women may experience more toxic side effects from chemotherapy. That's because the kidneys often function less effectively with age, and there's not as great a bone marrow reserve for generating new blood cells in older people.

"There's always been a concern that older women with breast cancer might be under-treated," said Dr. Yelena Novik, an oncologist at New York University Medical Center in New York City. "In clinical trials, the proportion of women over 70, and especially over 75, is very small, so it's hard to know the benefits and the risks. It's understood that older women are more likely to have other medical problems, such as heart disease, hypertension and diabetes, so the question is, should they be offered the same treatment as younger women?"

To answer that question, researchers from cancer centers around the country reviewed data from
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
2. Explaining chemotherapy-associated nausea
3. Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors
4. Class of Chemotherapy Drugs Helps Certain Breast Cancer Patients
5. Chemotherapy and tamoxifen reduce risk of second breast cancer
6. Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia
7. Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma
8. Extracellular protein sensitizes ovarian cancer cells to chemotherapy
9. Genes identified that protect against heart damage from chemotherapy
10. Subcutaneous administration of an antiemetic for treating vomiting caused by chemotherapy
11. Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemotherapy After Breast Cancer Surgery Effective for Older Women, Too
Chemotherapy After Breast Cancer Surgery Effective for Older Women, Too
(Date:11/25/2009)... that grew out of a collaboration between UCLA eng... to the nearly 10 million Americans who suffer fro...as hardening of the arteries, peripheral arterial ...n which narrowed arteries reduce blood flow to the... vascular disease, heart attack and stroke, and it...
(Date:11/25/2009)... was too short to draw definite conclusions, exper...ay News) -- In diabetic patients with blocked coro...n outcomes at one year whether patients undergo by... researchers report. , Bypass surgery has been ...coronary artery disease. However, less invasive ap...
(Date:11/25/2009)...Evaluation and treatment clinics to resume Monday,...us) November 25, 2009 -- Centegra Health System is...vaccine shots at four Centegra Primary Care (CPC) ...ine has arrived. The clinics are at CPC sites in H...ll be open as follows: ,   From 4:30 t...
(Date:11/25/2009)... neurological symptoms, study finds , ,...al side effects are among the potential problems f...ho were treated with cisplatin-based chemotherapy,...409 Norwegian men treated for unilateral testicula...follow-up survey conducted from 1998 to 2002. ,...
(Date:11/25/2009)...ewswire/-- MISSIONSkincare ®isproudtosupportG...rtofGNC,sannualSt.Jude ThanksandGiving campaign,$1... SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Additi...r$10donationatcheckoutatoneoftheir5,000+retailloca...orSt.Judeduringtheir2009 ThanksandGiving campaign....
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...U.S. research team led by Professor Claudio Soto f...nfectious ‘prion’ proteins behind such diseases in...ps to detect the proteins that cause Mad Cow disea...ining the method to find prions in people who died...
...le who smoke are often the ones who make fewer vis...arts. This happens in spite of the fact that smoki...s than others.// The finding holds true rega...al of Health Behavior, analyzed data gathered duri...
...st research findings challenge the efficacy of soy...tion of soy protein found in tofu and other soybea... //In addition, isoflavones found in soy may reduc...uality, or their duration was too short to lead to...
...archers from Ohio State University College of Medi...fering from epilepsy and not responding well to ot...of a vagus nerve stimulator (VNS) with significant...than 12 to help control or reduce the seizures tha...
...seling the family at home can effectively encourag...ly true for children suffering from diseases. ...d found that home-based counseling could lead to h...nificant risk factors for heart attacks, strokes a...
...is an inherited disease in which the oxygen-carryi...ing the red cells a twisted (sickled) shape that c...nd other disabling and sometimes fatal complicatio... of Haematology. The current treatment for chil...
Other Medicine News:Health News:Blood Test To Detect Creutzfeldt-Jakob Disease/Mad Cow Disease 2Health News:Soy Not Such A Wonder For Health? 2Health News:Children With Epilepsy Can Be Treated With Nerve Stimulation 2Health News:Initiation Of New Study To Help Children With Sickle Cell Anaemia 2
(Date:11/25/2009)...,, BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Reg...lopmentofantithromboticaptamerswithactivecontrolag...illbepresentingatthePiperJaffray21stAnnualHealthCa...r.Mazzo,spresentationwillbegivenat1:10pm(EST)onTue...,spipelinewithemphasisontheleaddevelopmentprogram,...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, UnitedStatesDentalDevicesM....reportlinker.com/p0158733/United-States-Dental-De...,, UnitedStatesDentalDevicesMarketAnalysisandFo...essentialsourceforin-depthinformationanddatarelati...
(Date:11/25/2009)...,, UNIONCITY,Calif.,Nov.25/PRNewswire-FirstC...ompanymanufacturingpoint-of-carebloodanalysissyste...fexecutiveofficer,willpresentatthe21stAnnualPiperJ...09at2:00p.m.ET.TheconferencewillbeheldattheNewYork..., Abaxisdevelops,manufacturesandmarketsportableblo...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Insmed CEO Resigns Due to Health Concerns 12633 1Insmed CEO Resigns Due to Health Concerns 12633 2Insmed CEO Resigns Due to Health Concerns 12633 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 1Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 2Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 4Drug May Stem Slide Into Alzheimers for Some 48955 1Drug May Stem Slide Into Alzheimers for Some 48955 2
...III study will evaluate effects of otelixizumab, a...n preservation of endogenous insulin ...il 9, 2008 /PRNewswire/ - Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...rd the initiation of a Phase III study of otelixiz...
...LANTA, April 9, 2008 Dutch biotechnology,company ...on and the South,African Tuberculosis Vaccine Init...ology data from a Phase I Ad35 tuberculosis vaccin... the World" conference (Atlanta,Georgia, April 9 t...uth,Africa and launched in May 2007, is the second...
Other Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6
... is variably N-glycosylated. The variation account...tween 43 and 56 kDa. Insulin-like growth factor bi...inity but do not bind insulin. Of the six distinct...t this time, IGFBP-3 has been shown to be the majo...
...00 tests per year through automatic scheduling and...rocessing up to 4 assays on 4 plates simultaneousl... presentation of the results, are controlled by Wi...ube rack) and 256 (POS-ID Linear Rack) samples can...
Immunosimplicity® Is-ENA Screen Test Kit
IMMULITE 2000 IGFBP-3
Medicine Products: